Buy or sell Civatech Oncology stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Civatech Oncology Stock

Civatech Oncology is a medical device company that develops polymer-based devices to treat cancer using localized low-dose-rate radiation.

About Civatech Oncology Stock

Civatech Oncology is a medical device company that develops polymer-based devices to treat cancer using localized low-dose-rate radiation. Because polymers are easy to manufacture in different shapes and formats, CivaTech's patented and patent-pending technology enables devices that can be designed and fabricated for specific tumor types. Its first product, the CivaString, has been granted FDA 510k clearance to treat any solid tumor. The company was founded in 2006 and is based in Durham, North Carolina, United States.

Funding History

June 2009$100K
November 2009$2K
March 2010$115K
December 2010$700K
April 2013$700K
June 2013$400K
April 2014$320K
July 2014$1.5M
April 2016$1.6M
September 2016$2.7M
August 2017$916K
December 2017$15K

Management

Co-Founder & Executive Chairman

Suzanne Troxler Babcock

Attorney-in-fact

Merrill M. Mason

Join 290K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo